Dineli Wickramasinghe

2.2k citations

24 papers · 1.6k indexed · h-index 17

Impact in

Hepatology top 2%
- Liver physiology and pathology
Aging top 5%

Papers in

Aging 2
- Genetics, Aging, and Longevity in Model Organisms 2
Hepatology 4
- Liver physiology and pathology 4

Co-authors: David F. Albertini Monica Kong-Beltran Karl M. Ebert Nerissa Mendoza Jennifer L. Stamos Ralph Schwall Lino Tessarollo Peter Donovan
Journals: Bioorganic & Medicinal Chemistry Letters (3 papers)Cancer Research (3 papers)Developmental Biology (2 papers)Mammalian Genome (2 papers)Molecular Cancer Therapeutics (1 paper)
Partner nations: United States Germany

In The Last Decade

Dineli Wickramasinghe

24 papers receiving 1.5k citations

Peers

Countries citing papers authored by Dineli Wickramasinghe

Since Specialization

Citations

This map shows the geographic impact of Dineli Wickramasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dineli Wickramasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dineli Wickramasinghe more than expected).

Fields of papers citing papers by Dineli Wickramasinghe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dineli Wickramasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dineli Wickramasinghe. The network helps show where Dineli Wickramasinghe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dineli Wickramasinghe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dineli Wickramasinghe Line = papers co-authored together Dineli Wickramasinghe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	AMG 925 Is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia Molecular Cancer Therapeutics ·Cong Li, Liqin Liu, Lingming Liang, Zhen Xia, Zhihong Li, Xianghong Wang, Lawrence R. McGee, カズオオオツカ, Angus M. Sinclair, Alexander Kamb, Dineli Wickramasinghe, Kang Dai	2014	27
2	Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies PLoS ONE ·Olivier Nolan-Stevaux, Wendy Zhong, Rachel S. Yang, Iwit Sunarti, Joe Hoover, Dineli Wickramasinghe, Astrid Ruefli-Brasse	2012	85
3	Abstract LB-249: Characterization of a novel potent and selective CDK4/6 inhibitor and a resistance mechanism Cancer Research ·Kang Dai, Cong Li, Lingming Liang, Minqing Rong, Jessica Orf, R. Michalec, Zhihong Li, Jiasheng Fu, Ji Ma, Quinn D. Kellerman, K. Czuminska, Julio C. Medina, Alexander Kamb, Dineli Wickramasinghe	2012	1
4	Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines Bioorganic & Medicinal Chemistry Letters ·Jacob A. Kaizerman, Wade H. Aaron, Songzhu An, Richard J. Austin, Matthew A. Brown, Greene Samantha, Tom Huang, Randall W. Hungate, Y. G. Liu, Michael G. Johnson, Gary Lee, Brian S. Lucas, Jessica Orf, Minqing Rong, Maria M. Toteva, Dineli Wickramasinghe, Guifen Xu, Qiuping Ye, Wendy Zhong, Dustin L. McMinn	2010	20
5	Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents Bioorganic & Medicinal Chemistry Letters ·Hilary P. Beck, Todd J. Kohn, Steven M. Rubenstein, K. S. Long, Ralf Schwandner, Athifah Rifqoh, Kang Dai, Cong Li, Lingming Liang, Holger Wesche, Brendon Frank, احمد اشرف, Dineli Wickramasinghe, Juan C. Jaén, Julio C. Medina, Randall W. Hungate, Shen Wang	2007	36
6	Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer Cancer Research ·Monica Kong-Beltran, Somasekar Seshagiri, Jiping Zha, Wenjing Zhu, Kaumudi Bhawe, Nerissa Mendoza, Thomas Holcomb, Kanan Pujara, Jeremy Stinson, Ling Fu, Christophe Severin, Linda Rangell, Ralph Schwall, Lukas C. Amler, Dineli Wickramasinghe, Robert L. Yauch	2006	372
7	CDK2/cyclinA inhibitors: Targeting the cyclinA recruitment site with small molecules derived from peptide leads Bioorganic & Medicinal Chemistry Letters ·Georgette M. Castanedo, Kevin Clark, Shumei Wang, Vickie Tsui, Mengling Wong, John B. Nicholas, Dineli Wickramasinghe, James C. Marsters, Daniel P. Sutherlin	2005	28
8	Met Activation and Receptor Dimerization in Cancer: A Role for the Sema Domain Cell Cycle ·Dineli Wickramasinghe, Monica Kong-Beltran	2005	28
9	The Sema domain of Met is necessary for receptor dimerization and activation Cancer Cell ·Monica Kong-Beltran, Jennifer L. Stamos, Dineli Wickramasinghe	2004	166
10	Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth. PubMed ·Nerissa Mendoza, Sharon Fong, Michael Malina, Hartmut Koeppen, Ralph Schwall, Dineli Wickramasinghe	2003	59
11	Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer. PubMed ·Nerissa Mendoza, Gail D. Lewis Phillips, Spogmay Riaz, Ralph Schwall, Dineli Wickramasinghe	2002	68
12	Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation Nature Genetics ·A. Jeannine Lincoln, Dineli Wickramasinghe, Paula Stein, Richard M. Schultz, Mary Ellen Palko, 順子宮坂, Lino Tessarollo, Peter Donovan	2002	220
13	Unusual Proteolytic Activation of Pro-hepatocyte Growth Factor by Plasma Kallikrein and Coagulation Factor XIa Journal of Biological Chemistry ·Mark Peek, Paul Moran, Nerissa Mendoza, Dineli Wickramasinghe, Daniel Kirchhofer	2002	59
14	Structure and promoter activity of the mouse CDC25A gene Mammalian Genome ·Michael Paskind, HG Sun, Paul M. Epstein, Jennifer Timm, Dineli Wickramasinghe, I Ketut Sutapa, VICTOR JEMIMA, Rosby Gomez, Jeffrey Voss	2000	7
15	The four cdc25 genes from the nematode Caenorhabditis elegans Gene ·Neville Ashcroft, Mary Kosinski, Dineli Wickramasinghe, Peter Donovan, Andy Golden	1998	29
16	The Cdc25 genes map to mouse Chromosomes 2, 9, and 18 Mammalian Genome ·Leslie F. Lock, Dineli Wickramasinghe, Mary K. Ernst, Debra J. Gilbert, Neal G. Copeland, N.A. Jenkins, Peter J. Donovan	1996	5
17	Cycling with CDKs Trends in Cell Biology ·Leslie F. Lock, Dineli Wickramasinghe	1994	4
18	4 Cell Cycle Control during Mammalian Oogenesis Current topics in developmental biology ·Dineli Wickramasinghe, David F. Albertini	1993	25
19	Centrosome phosphorylation and the developmental expression of meiotic competence in mouse oocytes Developmental Biology ·Dineli Wickramasinghe, David F. Albertini	1992	53
20	Meiotic competence acquisition is associated with the appearance of M-phase characteristics in growing mouse oocytes Developmental Biology ·Dineli Wickramasinghe, Karl M. Ebert, David F. Albertini	1991	195

About Dineli Wickramasinghe

Dineli Wickramasinghe is a scholar working on Aging, Hepatology, Cell Biology, Oncology and Molecular Biology, having authored 24 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver physiology and pathology (4 papers), Microtubule and mitosis dynamics (4 papers), Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers), Genomics and Chromatin Dynamics (4 papers), Reproductive Biology and Fertility (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Genetics, Aging, and Longevity in Model Organisms (2 papers). The work is most often cited by research in Hepatology (340 citations), Aging (54 citations), Reproductive Medicine (169 citations), Molecular Biology (953 citations) and Public Health, Environmental and Occupational Health (401 citations). Dineli Wickramasinghe has collaborated with scholars based in United States and Germany. Frequent co-authors include David F. Albertini, Monica Kong-Beltran, Karl M. Ebert, Nerissa Mendoza, Jennifer L. Stamos, Ralph Schwall, Lino Tessarollo, Peter Donovan, Paula Stein and Mary Ellen Palko. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cancer Research, Developmental Biology, Mammalian Genome and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact